0002160768-26-000001.txt : 20261019 0002160768-26-000001.hdr.sgml : 20261019 20261019085936 ACCESSION NUMBER: 0002160768-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20261019 DATE AS OF CHANGE: 20261019 EFFECTIVENESS DATE: 20261019 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Theravie Pharma, Inc. CENTRAL INDEX KEY: 0002160768 ORGANIZATION NAME: EIN: 414992021 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-601656 FILM NUMBER: 261467647 BUSINESS ADDRESS: STREET 1: 8525 GIBBS DRIVE STREET 2: SUITE 304 CITY: SAN DIEGO STATE: CA ZIP: 92123 BUSINESS PHONE: 858-308-2977 MAIL ADDRESS: STREET 1: 8525 GIBBS DRIVE STREET 2: SUITE 304 CITY: SAN DIEGO STATE: CA ZIP: 92123 D 1 primary_doc.xml X0708 D LIVE 0002160768 Theravie Pharma, Inc. 8525 GIBBS DRIVE SUITE 304 SAN DIEGO CA CALIFORNIA 92123 858-308-2977 DELAWARE None None Corporation true 2025 Samia Lina Helena Almoughrabie 8525 Gibbs Drive Suite 304 San Diego CA CALIFORNIA 92123 Executive Officer Director Richard Louis Gallo 8525 Gibbs Driver Suite 304 San Diego CA CALIFORNIA 92123 Executive Officer Director Biotechnology Decline to Disclose 06b false 2026-09-29 false true true Simple Agreement for Future Equity (SAFE), a contractual right to receive equity securities upon the occurrence of specified future financing events. false 0 2250000 750000 1500000 false 1 0 0 0 false Theravie Pharma, Inc. Samia Lina Helena Almoughrabie Samia Lina Helena Almoughrabie President of the Issuer 2026-10-08